Blog Posts

News Alert

Mississippi House Passes 340B Contract Pharmacy Bill, Two Days After Senate Passes Similar Bill

The Mississippi House passed, 83-31, a bill that would prohibit drugmaker 340B contract pharmacy restrictions in the state.
The Mississippi state house yesterday passed a bill to bar drugmaker 340B contract pharmacy restrictions and certain 340B-specific pharmacy benefit [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Exclusive

Imminent Enforcement of Arkansas 340B Contract Pharmacy Law to Follow Court Decision Upholding It

Arkansas Insurance Department office sign
The Arkansas Insurance Department will imminently enforce a state 340B contract pharmacy law following a key federal appeals court decision.
After a federal appeals court recently upheld Arkansas’ 340B contract pharmacy law, the state will initiate enforcement against 14 drugmakers [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Mississippi Senate Unanimously Passes 340B Contract Pharmacy Bill After Similar Legislation Dies in Florida

The Mississippi state senate unanimously passed a bill to bar drugmaker 340B contract pharmacy restrictions and certain 340B-specific PBM policies.
The Mississippi Senate this week unanimously passed a bill to bar drugmaker 340B contract pharmacy restrictions and certain 340B-specific pharmacy [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

For Covered Entities, Integrated Care is No Longer an Option

SPONSORED CONTENT

While health leaders have touted the “whole health” approach of integrated healthcare for decades as a way to provide patients with better, more cost-effective care, the COVID-19 pandemic significantly accelerated the adoption and implementation of this model by prompting rapid expansions in telehealth and highlighting

Read More »

U.C. Berkeley Researcher Proposes 340B Be Limited to the Indigent or that Providers Pass on their Discounts to Insurance Industry

Dr. James Robinson, a health economist at University of California at Berkley, criticized hospitals’ “buy and bill” drug acquisition process.
A University of California at Berkeley academic is proposing a series of major reforms to the 340B discount drug program [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

HRSA Urges Federal Court to Reject Health Systems’ Challenge to 340B Child Site Registration Policy Reversal

HRSA asked a federal district court to dismiss 44 health systems' challenge to its 340B child site registration policy reversal.
The Health Resources and Services Administration (HRSA) has asked a federal court to dismiss a lawsuit from forty-four health systems [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Column: Key Takeaways from the SUSTAIN 340B Act and Things to Consider When Weighing In (Part 2)

Ted Slafsky, publisher and CEO of 340B Report, writes the second part of his two-part column on the Senate "group of six" 340B discussion draft.
In February, the U.S. Senate bipartisan “Group of Six” released an eagerly anticipated discussion draft bill and a bill summary/request [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report